LABEL Opioids Act of 2021

Bill: 117-s-2353
Sponsor: full_name: Sen. Markey, Edward J. [D-MA]
Introduced: 2021-07-15
Policy area: Crime and Law Enforcement
Latest action: action_date: 2021-07-15
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2021-07-15
action_desc: Introduced in Senate
text: <p><strong>Lessening Addiction By Enhancing Labeling Opioids Act of 2021 or the LABEL Opioids Act of 2021</strong></p> <p>This bill requires prescription opioids to contain a warning label specifying that the opioids may cause dependence, addiction, and overdose. A registrant (e.g., a pharmacist) who dispenses an opioid in violation of the labeling requirement is subject to penalties.</p>

tv_txt: II 117th CONGRESS 1st Session S. 2353 IN THE SENATE OF THE UNITED STATES July 15, 2021 Mr. Markey (for himself, Mr. Braun , and Mr. Manchin ) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To amend the Controlled Substances Act to require dispensers of certain opioids to affix on the container or package thereof a clear, concise warning that the opioid can cause dependence, addiction, and overdose, and for other purposes.

1. Short title This Act may be cited as the Lessening Addiction By Enhancing Labeling Opioids Act of 2021 or the LABEL Opioids Act of 2021 . 2. Lessening addiction by enhancing labeling of opioids (a) In general Section 305(c) of the Controlled Substances Act ( 21 U.S.C. 825(c) ) is amended by striking which shall provide that the label and all that follows and inserting the following: which shall provide that— (1) the label of a drug listed in schedule II, III, or IV shall, when dispensed to or for a patient, contain a clear, concise warning that it is a crime to transfer the drug to any person other than the patient; and (2) the label of any container or package containing an opioid listed in schedule II, III, IV, or V (other than a drug that is approved, or authorized for emergency use, by the Food and Drug Administration for the treatment of addiction or an opioid use disorder) shall, when dispensed to or for a patient, contain a clear, concise warning that the opioid dispensed can cause dependence, addiction, and overdose. . (b) Prohibited act Section 402(a)(3) of the Controlled Substances Act ( 21 U.S.C. 842(a)(3) ) is amended by inserting or dispense after distribute . (c) Regulations (1) Regulations Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services shall prescribe final regulations to implement the amendments made by subsections (a) and (b), which regulations shall be effective beginning on the date that is 2 years after the date of enactment of this Act. (2) Interim rules The Secretary of Health and Human Services may issue the regulations required under paragraph (1) by interim rule to the extent necessary to comply with the timing requirement in that paragraph. (d) Applicability The amendment made by subsection (b) applies beginning on the date that is 2 years after the date of enactment of this Act.